share_log

Irwin Naturals, Numinus, Field Trip: Sector Analyst Compares Footprints, Cash, Organic Growth

Irwin Naturals, Numinus, Field Trip: Sector Analyst Compares Footprints, Cash, Organic Growth

Irwin Naturals、Numinus、Field Trip:行业分析师比较了足迹、现金、有机增长
Benzinga Real-time News ·  2023/01/24 12:07
The Analyst
《分析师》
Analyst Pablo Zuanic from Cantor Fitzgerald kept an Overweight rating for Irwin Naturals (CSE:IWIN) (OTC:IWINF) but lowered its 12-month price target to US$6.00 (C$8.05) from US$6.20 "on adjusted estimates."
分析员巴勃罗·祖阿尼奇Fitzgerald对Irwin Naturals(CSE:IWIN)(场外交易代码:IWINF)维持增持评级,但根据调整后的估计,将其12个月目标价从6.20美元下调至6.00美元(8.05加元)。
The Thesis
这篇论文是
Zuanic highlighted the "potential approval of various forms of psychedelics-assisted therapy, which should provide a boost for the mental health clinics sector (where stocks remain mostly under the radar)."
祖阿尼克强调说,“可能会批准各种形式的迷幻药辅助治疗,这应该会提振精神健康诊所部门(该部门的股票大多仍不受关注)。”
Irwin Naturals remains focused on its "roll-up strategy" of the mental health clinics industry, but "it has pushed out targets (100 clinics by end of CY24 vs. CY23 before)," Zuanic said in his analyst note on Monday...
Irwin Naturals仍然专注于其心理健康诊所行业的“汇总战略”...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发